AstraZeneca and Daiichi Sankyo confirmed today that they have ... It's not clear yet if they will adopt the same go-to-market strategy in Europe. Preliminary results from TROPION-Lung05 reported ...
Sharing a similar sentiment, Markus Kosch, head of Europe and Canada oncology business division, Daiichi Sankyo, said: “Greater public understanding of breast cancer and metastatic breast cancer is ...
MUNICH--(BUSINESS WIRE)-- Esperion Therapeutics, Inc. (NASDAQ: ESPR) and Daiichi Sankyo Europe GmbH (DSE) the European headquarter organization of the Japanese pharmaceutical company Daiichi ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback